Rheumatology treats musculoskeletal and autoimmune diseases, including arthritis, lupus, gout, and vasculitis.
Send us all your questions or requests, and our expert team will assist you.
The clinical presentation of lupus is notoriously variable, earning it the moniker “the great imitator.” Symptoms can range from mild fatigue and joint pain to life-threatening organ failure. The disease is characterized by a relapsing-remitting course, where periods of active illness, known as flares, alternate with periods of relative quiescence or remission. This unpredictability is a defining feature of the condition, requiring constant vigilance and monitoring. The systemic nature of the disease means that symptoms often appear in clusters, affecting multiple organ systems simultaneously or sequentially over time.
Constitutional symptoms are almost universally present during active disease. Profuse fatigue is the most common and often the most debilitating complaint, affecting the majority of patients. This fatigue is not merely tiredness but a profound exhaustion that does not resolve with rest, likely driven by the high metabolic cost of chronic inflammation and elevated cytokine levels. Unexplained fevers are another hallmark, often signaling an impending flare or active serositis. Weight loss can occur during active disease due to the catabolic state induced by inflammation, while weight gain may result from fluid retention associated with kidney involvement or from corticosteroid treatment.
The skin is one of the most frequently affected organs in lupus, and cutaneous symptoms often serve as the first visible sign of the disease. The classic acute cutaneous lupus presentation is the malar rash, also known as the butterfly rash. This is an erythematous, flat or raised rash that spans across the bridge of the nose and cheeks, sparing the nasolabial folds. It is photosensitive, meaning it precipitates or is exacerbated by exposure to ultraviolet light.
Photosensitivity is a broader symptom in lupus, where exposure to sunlight triggers not only skin rashes but also systemic flares, including joint pain and fatigue. This occurs because UV radiation induces apoptosis in skin cells, releasing nuclear antigens that the immune system targets. Subacute cutaneous lupus presents with annular, polycyclic lesions that are often scaly but do not scar. Chronic cutaneous lupus, or discoid lupus, manifests as thick, scaly plaques that can cause scarring and permanent pigment changes.
Mucosal ulcers are another common feature, typically painless and found on the hard palate of the mouth or inside the nose. These ulcers are a sign of active vasculitis or inflammation of the small blood vessels. Hair loss, or alopecia, can be diffuse, resulting in thinning hair, or patchy, related to discoid lesions on the scalp. The integrity of the skin and mucosa is compromised by the deposition of immunoglobulins at the dermal-epidermal junction, a finding often confirmed by skin biopsy.
Arthritis and arthralgia are among the most frequent clinical findings in lupus. The arthritis of lupus is typically polyarticular, affecting multiple joints, and symmetric, mirroring the pattern seen in rheumatoid arthritis. However, a key distinction is that lupus arthritis is generally non-erosive. While it causes pain, swelling, and morning stiffness, it rarely leads to the destruction of bone or cartilage seen in other inflammatory arthritides.
Jaccoud arthropathy is a specific condition seen in long-standing lupus, characterized by reversible deformities of the hands caused by ligament laxity rather than bone erosion. Patients may also experience myalgia (muscle pain) and muscle weakness. In some cases, distinct myositis, or inflammation of the muscle tissue, can occur, evidenced by elevated muscle enzymes. The chronic inflammation can also lead to avascular necrosis, particularly of the femoral head. In this condition, bone tissue dies due to an interrupted blood supply, often exacerbated by high-dose steroid use.
Kidney involvement, termed lupus nephritis, constitutes the most significant predictor of morbidity and mortality in systemic lupus. It occurs when immune complexes deposit in the glomeruli, the kidney’s filtering units. This deposition triggers an inflammatory response that can damage the delicate filtration barrier, leading to the leakage of protein and blood cells into the urine.
Lupus nephritis is clinically silent in its early stages, detected only through urinalysis showing proteinuria or hematuria. As the damage progresses, patients may develop edema, particularly in the lower legs and around the eyes, due to albumin loss. Hypertension often develops as renal function declines. Without effective treatment, the inflammation leads to scarring of the kidneys, known as glomerulosclerosis and interstitial fibrosis, ultimately resulting in end-stage renal disease requiring dialysis or transplantation. The regenerative capacity of the kidney is limited once fibrosis sets in, making early detection and aggressive management of nephritis a paramount priority.
The central nervous system can be a target of the autoimmune attack, a condition known as neuropsychiatric systemic lupus erythematosus. The symptoms are diverse and can range from mild cognitive dysfunction, often described by patients as brain fog, to severe manifestations such as seizures, psychosis, and stroke. Headaches, particularly migraines, are common. The pathology involves both the direct effects of autoantibodies on neuronal cells and secondary effects from vasculitis or clotting disorders affecting brain blood flow.
Serositis refers to inflammation of the serous membranes lining the chest and abdominal cavities. Pleuritis, inflammation of the lung lining, causes sharp chest pain that worsens with deep breathing. Pericarditis, inflammation of the sac surrounding the heart, can cause chest pain and fluid accumulation that may compress the heart. These conditions reflect the systemic nature of the inflammation and can be acute and painful, often requiring immediate anti-inflammatory intervention.
Lupus frequently affects the blood cells, leading to cytopenias. Anemia is common and can be due to chronic inflammation, kidney disease, or autoimmune hemolytic anemia, where antibodies destroy red blood cells. Leukopenia (low white blood cell count) and thrombocytopenia (low platelet count) are also frequent, increasing the risk of infection and bleeding, respectively.
A distinct but related condition often seen in lupus patients is Antiphospholipid Syndrome. This involves antibodies that target phospholipid proteins, increasing the risk of blood clots in both arteries and veins. This can lead to deep vein thrombosis, pulmonary embolism, and stroke. In pregnancy, it is a significant cause of recurrent miscarriage and preeclampsia. The vascular endothelium is a critical target in lupus, and chronic endothelial damage contributes to accelerated atherosclerosis, making cardiovascular disease a leading cause of long-term complications.
Send us all your questions or requests, and our expert team will assist you.
The joint pain in lupus, while inflammatory and causing stiffness and swelling, is typically non-erosive. This means that, unlike rheumatoid arthritis, it does not usually cause destruction or permanent damage to the bones within the joint, although it can cause ligament laxity and reversible deformities.
The butterfly rash is photosensitive because ultraviolet radiation from the sun damages skin cells, leading to apoptosis (cell death). In patients with lupus, clearance of these dead cells is impaired, and the exposed nuclear material triggers an immune reaction at the site of sun exposure, worsening the rash and potentially triggering a systemic flare.
Kidney involvement is often silent in the early stages, meaning there are no physical symptoms like pain. The earliest warning signs are detected through laboratory tests, specifically the presence of protein (proteinuria) or red blood cells (hematuria) in the urine. Physical signs, such as ankle swelling or puffy eyes, appear only after significant protein loss.
Lupus can cause the immune system to attack and destroy blood cells. This leads to anemia (low red blood cells, causing fatigue), leukopenia (low white blood cells, increasing infection risk), and thrombocytopenia (low platelets, increasing bleeding risk). It is a direct autoimmune destruction of blood cells.
Brain fog refers to cognitive dysfunction characterized by difficulties with memory, concentration, and mental clarity. It is a manifestation of neuropsychiatric lupus and is thought to be caused by inflammatory cytokines affecting brain function or micro-vascular changes restricting blood flow to some regions of the brain.
Your Comparison List (you must select at least 2 packages)
